Finland's Financial Supervisory Authority (FIN-FSA) has imposed a combined penalty payment of EUR 30,000 on the former listed company BBS-Bioactive Bone Substitutes Plc for failing to meet listed companies’ notification obligations under the EU Market Abuse Regulation, including not notifying three persons discharging managerial responsibilities of their duties on managers’ transactions. The omissions covered the period from 28 February 2018 to 22 November 2023. The notification obligation is intended to remind managers of their requirement to notify transactions and of the prohibition on trading during a closed period. The penalty payment, payable to the State, was set following an overall assessment focusing in particular on the nature, extent and duration of the omissions. The decision is not yet legally binding, and the company may appeal to the Helsinki Administrative Court within 30 days of receiving notice of the decision.
Finanssivalvonta 2025-03-04
Finland's Financial Supervisory Authority imposes EUR 30,000 penalty payment on BBS-Bioactive Bone Substitutes for Market Abuse Regulation notification omissions
Finland's Financial Supervisory Authority (FIN-FSA) fined BBS-Bioactive Bone Substitutes Plc EUR 30,000 for failing to meet EU Market Abuse Regulation notification obligations. The violations involved not informing three managers of their transaction duties from February 2018 to November 2023. The decision is not legally binding, and the company can appeal within 30 days.